# Tailored Juice-guided Eradication Therapy

> **NCT04061447** · NA · COMPLETED · sponsor: **Kaohsiung Medical University** · enrollment: 182 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** susceptibility-guided therapy
- **DRUG:** empirical clarithromycin-based triple therapy

## Key facts

- **NCT ID:** NCT04061447
- **Lead sponsor:** Kaohsiung Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-05
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04061447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04061447, "Tailored Juice-guided Eradication Therapy". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04061447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
